Pharmacosmos initiates phase III clinical trial of trilaciclib in limited-stage small cell lung cancer MORRISTOWN, NJ, ...

Pfizer Inc. (NYSE: PFE) today announced positive topline results from the randomized Phase 2 FOURLIGHT-1 study evaluating atirmociclib in combination ...

Retrospective, single-center design and limited power render findings hypothesis-generating, supporting prospective ...

Ovarian cancer (OC) is a "silent killer" with an annual incidence of 11.2 per 100,000 and mortality of 7.6 per 100,000. Most cases are diagnosed at ...

Biotheryx, Inc., a biopharmaceutical company focused on the discovery and development of first-in-class protein degraders for cancer and inflammatory diseases, today announced that the first patient ...

Proteins, one of the smallest building blocks of life on Earth, hold promise for answering some of biology's biggest ...

Extended IBTROZI follow up highlights durable clinical response Safety profile remains consistent across treated patient ...

Since the conflict began last month, sending crude oil prices soaring, EV makers such as Vietnam's VinFast and homegrown Ola Electric have offered discounts to wean consumers away from internal ...

Government, academia, and industry have come together to help push quantum technologies from research into the real world. When most people hear the word “quantum,” they might think of either ...

In this article, we will discuss the 13 Best Growth Stocks to Buy Right Now. On March 16, Chief Investment Strategist at Hightower Stephanie Link and Chief Investment Officer at NFJ Investment Group ...

The University of South Africa has placed one of the country’s leading scientists at the forefront of research aimed at ...

CHENGDU, China, March 18, 2026 /PRNewswire/ -- The 2026 European Lung Cancer Congress (ELCC) will be held in Copenhagen, Denmark, from March 25 to 28, 2026 (local time). At this congress, the final OS ...